EGF and neoplasm: Hanahan and Weinberg [2] argue in their study that somatic mutations in some components of major intracellular downstream proliferative pathways, physiologically activated by EGF/EGFR complexes, are mechanisms that are routinely established in some tumour types to achieve a sustained proliferative signal.